Accumulating studies have reported the involvement of FOXM1 in the progression of tumors including lung cancer, gastric cancer, breast cancer, and epithelial ovarian cancer (Hsieh et al., 2019; Bai et al., 2019b; Ring et al., 2018; Wang et al., 2016b). Here, FOXM1 is linked to ovarian carcinoma.